MORGAN STANLEY PLC/PUT/PFIZER INC/20/0.1/16.01.26 Share Price

Warrant

DE000ME5G114

Delayed Börse Stuttgart 11:50:05 12/07/2024 BST
0.105 EUR -5.41% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/20/0.1/16.01.26
Current month-2.63%
1 month+13.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
12/07/24 0.105 -5.41%
11/07/24 0.111 -1.77%
10/07/24 0.113 -5.83%
09/07/24 0.12 +0.84%
08/07/24 0.119 +1.71%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 11:50 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN ME5G11
ISINDE000ME5G114
Date issued 15/12/2023
Strike 20 $
Maturity 16/01/2026 (554 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.236
Lowest since issue 0.083
Delta-0.14x
Omega 3.561
Premium34.28x
Gearing24.6x
Moneyness 0.6978
Difference Strike -8.66 $
Difference Strike %-43.30%
Spread 0.004
Spread %3.67%
Theoretical value 0.1070
Implied Volatility 35.19 %
Total Loss Probability 71.89 %
Intrinsic value 0.000000
Present value 0.1070
Break even 18.83 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66 USD
Average target price
32.01 USD
Spread / Average Target
+11.68%
Consensus